RX Drugnews homepage



  • Claritin Reditabs 24 Hour Non-Drowsy Tablets (Schering-Plough)

    Drug Facts:

    Active Ingredient

    (in each tablet):          Purpose:

    Loratadine 10 mg.............................Antihistamine

    Uses:    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose · itchy, watery eyes
    • sneezing · itching of the nose or throat

    Warnings:    Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

    When using this product do not take more than directed. Taking more than directed may cause drowsiness.

    Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

    Directions:

    • place 1 tablet on tongue; tablet disintegrates, with or without water

    adults and children 6 years and over
    1 tablet daily; not more than
    1 tablet in 24 hours
    children under 6 years of age
    ask a doctor
    consumers with liver or kidney disease
    ask a doctor

    Other Information:

    • safety sealed: do not use if interior foil pouch or individual blister unit imprinted with Claritin® RediTabs® inside the foil pouch is open or torn
    • store between 20°C to 25°C (68°F to 77°F)
    • keep in a dry place
    • use within 6 months of opening foil pouch
    • use tablet immediately after opening individual blister

    Inactive Ingredients:    citric acid, gelatin, mannitol, mint flavor

    How Supplied:    Boxes of 4, 10, and 20 tablets

    Questions or comments?

    1-800-CLARITIN (1-800-252-7484) or www.claritin.com


Subscribe to the "News" RSS Feed RSS

  ۞



 

About Us   |  Privacy Policy   |  Terms of Use   |  Contact Us  

© 2012 RxDrug News 1999-2016. All rights reserved